MedTrace Logo

Development of a Clinical and Biological Database in Peritoneal Carcinosis (BCB CARCINOSE)

NCT04221464 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2025-02-12

No results posted yet for this study

Summary

The creation of a prospective clinical-biological base dedicated to peritoneal carcinosis must therefore be able to serve as a support for this essential search for transfer.

Conditions

  • Cancer
  • Peritoneal Carcinosis

Interventions

BIOLOGICAL

biological collection

Blood samples collected before any treatment (if chemotherapy for example), at every surgery, one month after surgery, at progression

OTHER

Tissues collections

Tumours and not tumours tissues will be collected before any treatment (if chemotherapy for example), at every surgery, one month after surgery, at progression

Sponsors & Collaborators

  • Institut du Cancer de Montpellier - Val d'Aurelle

    lead OTHER

Principal Investigators

  • François QUENET,MD · Institut régional du cancer de Montpellier

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-25
Primary Completion
2028-02-29
Completion
2038-02-28

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04221464 on ClinicalTrials.gov